" " indicates required fields
Every decision. Every change. Human or AI.
Traceable from design to field.
Regulators do not just want your final compliance package. They want to see the full chain of evidence from design intent to postmarket surveillance. EVSec maintains that chain automatically, across your entire product lifecycle, for both human and AI-driven decisions.
End to end
Automated
0
Real-time
Security requirements live in one tool. Test evidence in another. SBOM in a third. AI-driven decisions in none of them. No system connects them into a single auditable chain.
When a regulator requests evidence, teams spend weeks pulling records from disconnected systems and assembling them by hand.
Each new version creates new traceability requirements. Linking updated controls and tests back to original design intent is done manually, if at all.
When a field vulnerability surfaces, teams cannot quickly show which design decision, control, or test should have caught it. The investigation starts from scratch.
Point solutions track artifacts
EVSec traces the full chain of evidence
FDA 524B
ISO/SAE 21434
UN R155
IEC 62443
ISO 14971
EU CRA
NIST SSDF
Auto-ISAC ATM
AIS 189
DORA
IEC 81001-5-1
ASPICE
"When the FDA requested our full change history, we pulled the complete traceability report in minutes. That used to take us three weeks."
Medical Device Manufacturer
CRO
C2A Security
VP and GM, Medical Technology
C2A Security
Ken Zalevsky brings over 20 years of medical device cybersecurity experience to his role at C2A Security, where he serves as VP and GM, Medical Technology, following the acquisition of Vigilant Ops in October 2025. A former Bayer executive, Ken founded Vigilant Ops in 2019 after witnessing the consequences of inadequate technical preparation in the healthcare industry. He is an active contributor to CISA’s SBOM working groups and a frequent speaker on software supply chain security. Ken’s mission: transform SBOM from a compliance checkbox into operational intelligence that keeps patients safe while streamlining regulatory processes.